Carvalho Constança, Peste Filipa, Marques Tiago A, Knight Andrew, Vicente Luís M
Centro de Filosofia das Ciências da Universidade de Lisboa (CFCUL), Faculdade de Ciências da Universidade de Lisboa, Lisbon, Portugal.
Centre for Environmental and Marine Studies, Departamento de Biologia, Universidade de Aveiro, Aveiro, Portugal.
Front Psychol. 2020 Jul 14;11:1486. doi: 10.3389/fpsyg.2020.01486. eCollection 2020.
Major depressive disorder (MDD) is the most severe depression type and one of the leading causes of morbidity worldwide. Animal models are widely used to understand MDD etiology, pathogenesis, and treatment, but the efficacy of this research for patients has barely been systematically evaluated. Such evaluation is important given the resource consumption and ethical concerns incurred by animal use. We used the citation tracking facilities within Web of Science and Scopus to locate citations of original research papers on rats related to MDD published prior to 2013-to allow adequate time for citations-identified in PubMed and Scopus by relevant search terms. Resulting citations were thematically coded in eight categories, and descriptive statistics were calculated. 178 publications describing relevant rat studies were identified. They were cited 8,712 times. More than half (4,633) of their citations were by other animal studies. 794 (less than 10%) were by human medical papers. Citation analysis indicates that rat model research has contributed very little to the contemporary clinical understanding of MDD. This suggests a misuse of limited funding hence supporting a change in allocation of research and development funds targeting this disorder to maximise benefits for patients.
重度抑郁症(MDD)是最严重的抑郁症类型,也是全球发病的主要原因之一。动物模型被广泛用于了解MDD的病因、发病机制和治疗方法,但这项研究对患者的疗效几乎没有得到系统评估。考虑到动物使用所产生的资源消耗和伦理问题,这种评估很重要。我们利用科学网和Scopus中的引文跟踪工具,查找2013年之前发表的与MDD相关的大鼠原创研究论文的引文——以便有足够的时间让相关搜索词在PubMed和Scopus中识别出引文。对所得引文按八个类别进行主题编码,并计算描述性统计数据。共识别出178篇描述相关大鼠研究的出版物。它们被引用了8712次。其中一半以上(4633次)的引用来自其他动物研究。794次(不到10%)的引用来自人类医学论文。引文分析表明,大鼠模型研究对当代MDD临床理解的贡献微乎其微。这表明有限资金的滥用,因此支持改变针对该疾病的研发资金分配,以最大限度地为患者带来益处。